Financial Planning Experts

Breaking Financial News and Information
Menu
  • Entrepreneurs
  • World Finance
  • Breaking News
  • Markets
  • Real Estate
  • Privacy Policy
  • Contact Us

Amgen stock surges, provides nearly 80-point support to the Dow after Morgan Stanley turns bullish

Bill Muskegy October 11, 2022

Shares of Amgen Inc.
AMGN,
+6.83%
leapt 5.2% in morning trading Tuesday, enough to pace the Dow Jones Industrial Average’s
DJIA,
+0.15%
gainers, after Morgan Stanley turned bullish on the biotechnology company. Amgen’s stock price gain of $12.04 was adding about 79 points to the Dow’s price, while the Dow fell 109 points, or 0.4%. Analyst Matthew Harrison raised his rating on Amgen to overweight, as his $279 stock price target implies TK% upside from current levels. Although Amgen faces risk from biosimilar exposure over the longer term, in the current economic and volatile market environment, Harrison is now bullish given Amgen’s “defensive positioning,” and as its AMG133 drug offers “an attractive call option” in the obesity market. The stock has rallied 8.5% year to date, while the iShares Biotechnology ETF
IBB,
+0.18%
has dropped 23.4% and the Dow has declined 19.9%.

Prev Article
Next Article

About The Author

Bill Muskegy



Recent Posts

  • Problems Blockchain Solves
  • Biggest Crypto Events 2023
  • Biggest Crypto Events 2022
  • Best Crypto Research Tools
  • Most Reliable Crypto News

Financial Planning Experts

Breaking Financial News and Information
Copyright © 2023 Financial Planning Experts
Theme by Financial Planning

Ad Blocker Detected

Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker.

Refresh